Number | Exon/Intron | Nucleotide change | Protein change | Location | Mutation type | Consequences | Phenotype | Inheritance | Reference |
---|---|---|---|---|---|---|---|---|---|
749 | 15 | c.2836C>T | p.Arg946Cys | DIIS5-S6 | Missense | P/﹢→N (180); LOF | SMEI | De novo | Fukuma G.2004 |
SMEB | NA | Fukuma G.2004 | |||||||
SMEI | 2De novo | Zuberi SM.2011 | |||||||
SMEI | De novo | Volkers L.2011 | |||||||
SMEI | De novo | Wang JW.2012 | |||||||
SMEB | NA | Wang JW.2012 | |||||||
SME | NA | Xu X.2014 | |||||||
SME | NA | Lee HF.2014 | |||||||
Epilepsy and/or NDD | NA | Lindy AS.2018 |
Functional information:
Number | Nucleotide change | Protein change | Location | Phenotype | Functional defect type | Details of the major biophysical abnormalities. | Reference |
---|---|---|---|---|---|---|---|
19 | c.2836C>T | p.Arg946Cys(R946C) | DIIS5-S6 | SMEI | LOF | No measurable sodium current. | Volkers L.2011 |
[c.2836C>T] Clinical description |
---|
The R946C mutation was detected in a girl diagnosed with DS. She experienced her first seizure at age of 10 months, after a vaccination against DTwcP-IPV and Hib. The majority of her seizures were fever provoked GTCS. Valproate monotherapy controlled her seizure frequency to twice a year. She showed ataxia and a moderate developmental delay. Her IQ was 60 at the age of 5.5 years(Volkers L,et al. Eur J Neurosci. 2011 Oct;34(8): 1268-75. [21864321]). |
Copyright ©2014 Institute of Neuroscience and The Second Affiliated Hospital of Guangzhou Medical University
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China
Collaborative Innovation Center for Neurogenetics and Channelopathies, Guangzhou 510260, China.